Zhaohui Wang, DVM, MA
Assistant Research Professor, Surgery-Plastic/Reconstructive

Publications

• Wang, Z., Yoeli, D., Nakra, N., Huang, J., Li, B., Wang, Y., ... & Huang, C. A. (2022). 422.2: Investigating Galectin-3 as a Novel Therapeutic Target To Block Inflammation and Reduce Ischemia Reperfusion Injury During Vascular Composite Allograft Transplantation. Transplantation, 106(9S), S455.
• Wang, Z., Li, B., Wang, Y., Yoeli, D., Nakra, N., La Rosa, D., ... & Huang, C. A. (2022, June). Circulating Galectin-3 Levels Increase in Syngeneic Rat Recipients of Vascularized Composite Allografts Subjected to Prolonged Ischemia. In AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 22, pp. 632-633). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.
• MHSRS-22-07596 - POSTER SESSION 2 - #243 Galectin-3 Blockade Reduces Macrophage Infiltration Associated with Ischemia Reperfusion Injury in a Rat Hind Limb Transplant Model
• Qiu, Y., Qi, Z., Wang, Z., Cao, Y., Lu, L., Zhang, H. ... Wang, Z. (2023). EGF-IL2 bispecific and bivalent EGF fusion toxin efficacy against syngeneic head and neck cancer mouse models. Oncology Reports, 49, 37. https://doi.org/10.3892/or.2022.8474
• CCR4-IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T-cell lymphoma